NCT02028572

Brief Summary

Glaucoma is an optic neuropathy characterised by progressive degeneration of retinal ganglion cells and axons that leads to nerve fibre loss, optic disc cupping, and consecutive glaucomatous visual field defects. It is considered to be one of the major causes of blindness worldwide. It is a well accepted fact least 25 - 40% of retinal ganglion cells need to be lost before statistically detectable visual field defects appear on automated visual field testing, which is also consistent with post-mortem histologic findings in glaucomatous eyes. Since the damage associated with glaucoma is irreversible, and retinal nerve fibre layer loss is considered as an early sign of glaucomatous damage, its early detection and prevention is warranted. Retinal nerve fibre layer studies can be undertaken through non - invasive, reproducible technologies such as optical coherence tomography, scanning laser polarimetry etc. The purpose of the study is to evaluate the relationship between visual fields and retinal nerve fibre layer thickness as measured by Cirrus spectral domain optical coherence tomography with visual fields by Humphrey Field Analyser (HFA) in early and moderate primary open - angle glaucoma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 7, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

December 30, 2014

Status Verified

December 1, 2014

Enrollment Period

1.2 years

First QC Date

December 5, 2013

Last Update Submit

December 28, 2014

Conditions

Keywords

Structure function correlationOptical coherence tomographyRetinal Nerve fibre layer thicknessVisual fieldsPrimary open angle glaucoma

Outcome Measures

Primary Outcomes (1)

  • Correlation between retinal nerve fibre layer thickness measured by optical coherence tomography and mean sensitivity, mean deviation as reported by visual fields.

    The subjects shall be studied over an avergae period of 4 weeks from the presentation for the purpose of optical coherence tomography and visual field studies.

Secondary Outcomes (1)

  • Correlation between retinal nerve fibre layer thinning and scotomatous defects in visual fields in primary open angle glaucoma.

    The subjects shall be reviewed over an average period of 4 weeks to obtain the optical coherence tomography and visual field studies.

Study Arms (1)

Primary open angle glaucoma

Subjects diagnosed to have primary open angle glaucoma with intraocular pressure \> 21 mm Hg and characteristic glaucomatous damage to the optic nerve.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects presenting to the glaucoma clinic of a tertiary eye care hospital an diagnosed to have primary open angle glaucoma

You may qualify if:

  • Subjects visiting a glaucoma clinic diagnosed with primary open - angle glaucoma.
  • Subjects should have best corrected visual acuity not less than 6/18.
  • Refractive spherical error within the range of -6.00 dioptres to + 3.00 dioptres and cylindrical error within +/- 2.5 dioptres.
  • Visual fields examination of the subjects demonstrating field defects secondary to glaucomatous damage with mean deviation ranging from -2 to -10 decibels (db).
  • The visual fields of the subjects should be within the reliability criteria (\<20% fixation losses, false positives and false negatives).
  • The signal to noise ratio for a reliable Optical Coherence Tomograph - Retinal Nerve Fibre Layer scan shall not be less than 6.

You may not qualify if:

  • History of (H/O) retinal disease or photocoagulation.
  • H/O ocular trauma or surgery except an uncomplicated cataract surgery.
  • H/O other optic nerve disease except glaucoma
  • H/O amblyopia
  • Neurological disease which can affect visual fields.
  • Visually significant cataracts (Posterior Subcapsular Cataracts, \> N.S Grade II).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vasan Eye Care Hospital

Chennai, Tamil Nadu, 600015, India

Location

Related Publications (3)

  • Hood DC, Kardon RH. A framework for comparing structural and functional measures of glaucomatous damage. Prog Retin Eye Res. 2007 Nov;26(6):688-710. doi: 10.1016/j.preteyeres.2007.08.001. Epub 2007 Aug 21.

    PMID: 17889587BACKGROUND
  • El Beltagi TA, Bowd C, Boden C, Amini P, Sample PA, Zangwill LM, Weinreb RN. Retinal nerve fiber layer thickness measured with optical coherence tomography is related to visual function in glaucomatous eyes. Ophthalmology. 2003 Nov;110(11):2185-91. doi: 10.1016/S0161-6420(03)00860-1.

    PMID: 14597528BACKGROUND
  • Ajtony C, Balla Z, Somoskeoy S, Kovacs B. Relationship between visual field sensitivity and retinal nerve fiber layer thickness as measured by optical coherence tomography. Invest Ophthalmol Vis Sci. 2007 Jan;48(1):258-63. doi: 10.1167/iovs.06-0410.

    PMID: 17197541BACKGROUND

MeSH Terms

Conditions

Glaucoma, Open-Angle

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Study Officials

  • Dr.Venkatesh Sugantharaj, MS, DNB

    Vasan Eye Care Hospital

    STUDY DIRECTOR
  • Dr.RAMESH HARIHARAN, MBBS,DNB

    Vasan Eye Care Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Ophthalmologist

Study Record Dates

First Submitted

December 5, 2013

First Posted

January 7, 2014

Study Start

February 1, 2013

Primary Completion

May 1, 2014

Study Completion

June 1, 2014

Last Updated

December 30, 2014

Record last verified: 2014-12

Locations